Cargando...
Immunotherapy and Epigenetic Pathway Modulation in Glioblastoma Multiforme
Glioblastoma Multiforme (GBM) is the most common malignant primary brain tumor. Despite aggressive multimodality treatment it remains one of the most challenging and intractable cancers (1]. While current standard of care treatment for GBM is maximal safe surgical resection, systemic chemotherapy wi...
Gardado en:
| Publicado en: | Front Oncol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6243054/ https://ncbi.nlm.nih.gov/pubmed/30483476 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2018.00521 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|